Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aquestive Therapeutics (AQST)
NASDAQ:AQST
RESEARCH TOOLSreports
Holding AQST?
Track your performance easily
See the Price Targets and Ratings of:
AQST Analyst Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AQST Stock 12 Month Forecast
Average Price Target
$11.20
▲(206.85% Upside)
| Highest Price Target$17.00 | Average Price Target$11.20 | Lowest Price Target$9.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
12/20/24
Lake Street
Reiterated
12/19/24
Cantor Fitzgerald
Initiated
12/17/24
JMP Securities
Reiterated
12/02/24
Leerink Partners
Reiterated
12/02/24
Piper Sandler
Reiterated
10/25/24
Oppenheimer
$13
Buy
256.16%
Upside
Reiterated
08/08/24
Oppenheimer Keeps Their Buy Rating on Aquestive Therapeutics (AQST)
Alliance Global Partners
$7→$5.5
Buy
50.68%
Upside
Reiterated
05/09/24
Aquestive Therapeutics price target lowered to $5.50 from $7 at Alliance Global PartnersAquestive Therapeutics price target lowered to $5.50 from $7 at Alliance Global Partners
Raymond James
$7
Buy
91.78%
Upside
Initiated
03/27/24
Aquestive Therapeutics initiated with an Outperform at Raymond JamesAquestive Therapeutics initiated with an Outperform at Raymond James
Best Analysts Covering Aquestive Therapeutics
Which Analyst Should I Follow If I Want to Buy AQST and Sell After:
1 Month
xxx
Success Rate
8/13 ratings generated profit
Average Return
+1.87%
initiated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.54% of your transactions generating a profit, with an average return of +1.87% per trade.
3 Months
xxx
Success Rate
9/17 ratings generated profit
Average Return
+14.38%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.94% of your transactions generating a profit, with an average return of +14.38% per trade.
1 Year
Success Rate
11/17 ratings generated profit
Average Return
+63.45%
reiterated a buy rating 2 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +63.45% per trade.
2 Years
xxx
Success Rate
22/34 ratings generated profit
Average Return
+102.73%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 64.71% of your transactions generating a profit, with an average return of +102.73% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AQST Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
14
15
17
15
16
Buy
2
2
2
2
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
17
19
17
18
Each month's total comprises the sum of three months' worth of ratings.
AQST Financial Forecast
AQST Stock Forecast FAQ
What is AQST’s average 12-month price target, according to analysts?
Based on analyst ratings, Aquestive Therapeutics’s 12-month average price target is $11.20.
What is AQST’s upside potential, based on the analysts’ average price target?
Aquestive Therapeutics has 206.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AQST a Buy, Sell or Hold?
Aquestive Therapeutics has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Aquestive Therapeutics’s price target?
The average price target for Aquestive Therapeutics is $11.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $17.00 ,the lowest forecast is $9.00. The average price target represents 206.85% Increase from the current price of $3.65.
The highest analyst price target is $17.00 ,the lowest forecast is $9.00. The average price target represents 206.85% Increase from the current price of $3.65.
What do analysts say about Aquestive Therapeutics?
Aquestive Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of AQST?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.